IRME Ir-med, Inc.

Fundamentals / CIK 0001839133 / USD

Ir-med, Inc. reported $175K in total assets and a net loss of $2.35M through December 31, 2024 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open IRME in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

5 fiscal years (2020 to 2024), reported in USD.

$0$0$0-$4.59MFY 2020 Net Income: -$752K2020FY 2021 Net Income: -$3.72M2021FY 2022 Net Income: -$4.73M2022FY 2023 Net Income: -$4.91M2023FY 2024 Net Income: -$1.90M2024

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $710K $2.06M $1.89M $1.42M $409K
Operating Income -$1.94M -$4.91M -$4.76M -$3.67M -$730K
EBITDA -$1.92M -$4.89M -$4.75M -$3.67M -$729K
Income Before Tax $1.90M $4.91M $4.73M $3.72M -$752K
Net Income -$1.90M -$4.91M -$4.73M -$3.72M -$752K
Basic EPS -$0.03 -$0.07 -$0.07 -$0.06 -$0.02
Diluted EPS -$0.03 -$0.07 -$0.07 -$0.06 -$0.02
Basic Shares Outstanding -- 69.4M 67.6M 63.1M 30.0M
Diluted Shares Outstanding 70.5M 69.4M 67.6M -- --

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Research & Development $91K $23K $216K $205K $94K $195K $491K $469K
Operating Income -$286K -$253K -$324K -$601K -$358K -$658K -$1.26M -$1.20M
EBITDA -$282K -$250K -$320K -$597K -$354K -$649K -$1.26M -$1.19M
Net Income -$701K -$773K -$278K -$598K -$366K -$657K -$1.27M -$1.18M
Basic EPS -$0.01 -$0.01 -- -$0.01 -$0.01 -$0.01 -- -$0.02
Diluted EPS -$0.01 -$0.01 -- -$0.01 -$0.01 -$0.01 -- -$0.02
Basic Shares Outstanding 73.8M 71.3M -- 70.8M 70.3M 69.9M -- 68.8M
Diluted Shares Outstanding 73.8M 71.3M -- 70.8M 70.3M 69.9M -- 68.8M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $129K $767K $3.00M $2.81M $1.87M
Cash & Short-Term Investments $129K $767K $3.00M $2.81M $1.87M
Accounts Receivable, Net $76K $81K $55K $67K $218K
Total Current Assets $205K $848K $3.06M $2.88M $2.08M
Property, Plant & Equipment, Net $35K $56K $71K $31K $6.0K
Total Non-Current Assets $46K $151K $237K $61K $6.0K
Total Assets $251K $999K $3.29M $2.94M $2.09M
Accounts Payable $114K $64K $83K $58K $25K
Other Current Liabilities -- -- $162K -- --
Total Current Liabilities $545K $473K $662K $395K --
Long-Term Debt -- -- $40K -- --
Total Non-Current Liabilities $0 $161K $40K $177K --
Total Liabilities $545K $634K $702K $572K $689K
Total Debt (incl. Leases) -- $39K $154K -- --
Common Stock $70K $69K $68K $64K $54K
Retained Earnings -$16.74M -$14.84M -$9.93M -$5.20M -$1.48M
Total Stockholders' Equity -$294K $365K $2.59M $2.4K $1.40M
Total Equity -$294K $365K $2.59M $2.4K $1.40M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Cash & Cash Equivalents $63K $51K $129K $392K $753K $408K $767K $1.52M
Cash & Short-Term Investments $63K $51K $129K $392K $753K $408K $767K $1.52M
Accounts Receivable, Net $27K $30K $76K $51K $36K $55K $81K $83K
Total Current Assets $90K $81K $205K $443K $789K $463K $848K $1.61M
Property, Plant & Equipment, Net $29K $32K $35K $39K $42K $47K $56K $55K
Total Non-Current Assets $85K $43K $46K $90K $98K $116K $151K $166K
Total Assets $175K $124K $251K $533K $887K $579K $999K $1.77M
Accounts Payable $139K $144K $114K $68K -- -- $64K --
Total Current Liabilities $774K $617K $545K -- -- -- $473K $559K
Total Non-Current Liabilities $26K $0 $0 -- -- -- $161K $2.0K
Total Liabilities $800K $617K $545K $531K $524K $665K $634K $561K
Total Debt (incl. Leases) $42K -- -- -- -- -- $39K $2.0K
Common Stock $77K $72K $70K $70K $70K $69K $69K $69K
Retained Earnings -$18.21M -$17.51M -$16.74M -$16.46M -$15.86M -$15.50M -$14.84M -$13.57M
Total Stockholders' Equity -$625K -$493K -$294K $2.0K $363K -$86K $365K $1.21M
Total Equity -$625K -$493K -$294K $2.0K $363K -$86K $365K $1.21M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$1.90M -$4.91M -$4.73M -$3.72M -$752K
Depreciation & Amortization $21K $17K $10K $5.0K $1.0K
Stock-Based Compensation $485K $1.68M $1.33M $1.34M --
Change in Receivables $6.0K -$25K $35K -$38K -$16K
Change in Payables -$1.0K $6.0K $12K -$83K $320K
Operating Cash Flow -$1.39M -$3.23M -$3.38M -$2.48M -$402K
Capital Expenditure -- -$2.0K -$50K -$31K --
Free Cash Flow -- -$3.23M -$3.42M -$2.51M --
Investing Cash Flow -- -$2.0K -$59K -$61K --
Common Stock Issued -- -- -- -- $81K
Financing Cash Flow $750K $1.00M $3.62M $3.49M $2.04M
Net Change in Cash -$638K -$2.23M $187K $949K $1.63M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Net Income -$701K -$773K -$278K -$598K -$366K -$657K -$1.27M -$1.18M
Depreciation & Amortization $4.0K $3.0K $4.0K $4.0K $4.0K $9.0K $0 $4.0K
Stock-Based Compensation $87K $54K -$18K $197K $100K $206K $424K $383K
Change in Receivables $3.0K $46K -$24K -$15K $18K $27K $3.0K $16K
Change in Payables -$50K $40K $57K $10K -$122K $54K $82K -$35K
Operating Cash Flow -$71K -$110K -$261K -$395K -$372K -$358K -$754K -$811K
Financing Cash Flow $88K $31K -- -- -- -- -- --
Net Change in Cash $12K -$78K -$263K -$361K $345K -$359K -$757K -$812K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -- -1344.9% -182.6% -156727.1% -53.7%
Return on Assets (ROA) -756.6% -491.4% -143.7% -126.3% -36.0%
Current Ratio 0.38x 1.79x 4.62x 7.30x --
Quick Ratio 0.38x 1.79x 4.62x 7.30x --
Debt to Equity -- 0.11x 0.06x -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Return on Equity (ROE) -- -- -- -144600.0% -956.7% -- -1344.9% -472.6%
Return on Assets (ROA) -1342.9% -1625.0% -756.6% -542.6% -391.5% -728.2% -491.4% -323.1%
Current Ratio 0.12x 0.13x 0.38x -- -- -- 1.79x 2.87x
Quick Ratio 0.12x 0.13x 0.38x -- -- -- 1.79x 2.87x
Debt to Equity -- -- -- -- -- -- 0.11x 0.00x
Source: SEC EDGAR CompanyFacts (CIK 0001839133) · from September 30, 2020 Data through June 30, 2025 · synced Nov 21, 2026, 05:15 UTC · Open in terminal